|
⚲
|
| Keyboard |
| Braidwell LP
✚
|
|
|---|---|
| CRD # | 316988 |
| SEC # | 801-122966 |
| CIK # | 0001920938 |
| AUM | 4,985.0 M (2026-03-31) |
| Employees | 32 (59% Investors, 0% Brokers) |
| Phone | 866-453-3929 |
| Address | One Harbor Point, 2200 Atlantic Street Stamford, CT 06902 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Caris Life Sciences Inc | 0.1 | ||
| Neurocrine Biosciences Inc | 0.1 | ||
| Glaukos Corp | 0.1 | ||
| Xenon Pharmaceuticals Inc | 0.1 | ||
| Magenta Therapeutics Inc | 0.1 | ||
| Edgewise Therapeutics Inc | 0.1 | ||
| iRhythm Technologies Inc | 0.1 | ||
| Nuvalent Inc | 0.1 | ||
| Kodiak Sciences Inc | 0.1 | ||
| CG Oncology Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Braidwell Companion CMV 2024-1 LP | 2024-11-26 | 4.9 M | |
| HF | Braidwell Companion CMV 2024-1 Master Fund LP | 2024-11-26 | 5.1 M | |
| HF | Braidwell Companion CMV Transaction Master Fund LP - 2024-1 Series | 2024-11-26 | 6.4 M | |
| HF | Braidwell Companion CMV US LP - 2024-1 Series | 2024-11-26 | 6.6 M | |
| HF | Braidwell Companion CMV LP | [2021-12-01] | 66.5 M | |
| Filed 2022-04-08 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $500,000 · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| HF | Braidwell Companion CMV Master Fund LP | 2021-12-01 | ||
| HF | Braidwell Companion CMV Transaction Master Fund LP - 2023-1 Series | 2021-12-01 | ||
| HF | Braidwell Companion CMV US LP - 2023-1 Series | [2021-12-01] | 63.4 M | |
| Filed 2022-04-08 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $500,000 · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| HF | Braidwell Partners LP | [2021-12-01] | 2,865.7 M | 1,889.4 M |
| Filed 2026-02-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Braidwell Partners Master Fund LP | 2021-12-01 | 1,970.4 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 12 | 5.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 12 | 5.0 |
| By Discretionary | ||
| Discretionary | 12 | 5.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 12 | 5.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.7 | |
| United States Persons | 3.3 | |
| Total | 12 | 5.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Braidwell LP | Executive Officer | 6 | 2 | |
| Manish Mital | Executive Officer | 6 | 2 | |
| Braidwell GP LLC | Promoter | 6 | 2 | |
| Brian Kreiter | Executive Officer | 6 | 2 | |
| Alexander Karnal | Executive Officer | 5 | 2 | |
| Colin Bettison | Executive Officer | 2 | 1 | |
| Alexander Karal | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001920938] | |
| SC 13G | [0001920938] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Braidwell LP | Surrozen Inc/DE | [2026-02-17] |
| Braidwell LP | DBV Technologies Sa | [2023-02-14] |
| Braidwell LP | Crinetics Pharmaceuticals Inc | [2023-02-14] |
| Braidwell LP | Deciphera Pharmaceuticals Inc | [2023-02-14] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Comparable Firms | State | AUM |
|---|---|---|
|
Maplelane Capital LLC
✚
|
NY | 5,047.1 M |
|
Platinum Investment Management Limited
✚
|
5,038.5 M | |
|
Kirkoswald Capital Management Limited
✚
|
5,014.3 M | |
|
Finepoint Capital LP
✚
|
MA | 5,010.3 M |
|
Fiera Capital UK Limited
✚
|
4,989.3 M | |
|
Gulf International Bank UK Limited
✚
|
4,982.3 M | |
|
Hound Partners LLC
✚
|
NY | 4,976.9 M |
|
Empyrean Capital Partners LP
✚
|
CA | 4,969.1 M |
|
GSA Capital Partners LLP
✚
|
4,914.2 M | |
|
Advantage Advisers Multi-Manager LLC
✚
|
NY | 4,912.6 M |